General Information of Drug (ID: DM8CLG2)

Drug Name
Sodium orthovanadate Drug Info
Synonyms
13721-39-6; Trisodium vanadate; Sodium pervanadate; Sodium o-vanadate; Sodium vanadate (ortho); Trisodium tetraoxovanadate; Sodium tetraoxovanadate(3-); Vanadic acid, trisodium salt; TRISODIUM ORTHOVANADATE; Vanadic acid (H3VO4), sodium salt; UNII-7845MV6C8V; trisodium trioxido(oxo)vanadium; CCRIS 9063; Vanadic(II) acid, trisodium salt; EINECS 237-287-9; NSC 79534; Vanadate (VO43-), trisodium, (T-4)-; AI3-52157; Vanadate(VO4(3-)), trisodium; CHEBI:35607; 7845MV6C8V; Vanadic (II) Acid, Trisodium
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
61671
ChEBI ID
CHEBI:35607
CAS Number
CAS 13721-39-6
TTD Drug ID
DM8CLG2

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Protein tyrosine phosphatase IVA 3 (PRL-3) TT7YM8D TP4A3_HUMAN Inhibitor [1]

References

1 Structure of human PRL-3, the phosphatase associated with cancer metastasis. FEBS Lett. 2004 May 7;565(1-3):181-7.